Announced Sat, 25 Jul · 12:52 IST
Board meeting on 4 Aug 2026 to consider Q1 FY27 results
Results View source PDF
SUDEEPPHRM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
—1-day move
₹820.35
prior close
₹856.40
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+2.3+0.1+0.2+1.4——————————
Up moveDown movePending
AI summary
Sudeep Pharma has scheduled a Board meeting on 4 August 2026 to consider and approve the unaudited standalone and consolidated financial results for Q1 FY27 (quarter ended 30 June 2026). The trading window for insiders is closed from 1 July 2026 to 6 August 2026. No financial figures or outcomes are disclosed in this intimation filing, which is a routine SEBI compliance update.
Likely market impact
Routine compliance filing ahead of Q1 results. Investors should watch for actual numbers on or after 4 August 2026.